Glial cell and inflammatory responses to retinal laser treatment: Comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 3, 2013, Pages 2319-2332

  Chidlow, Glyn ^a   Shibeeb, O'Sam ^a,b   Plunkett, Malcolm ^c   Casson, Robert J ^a,b   Wood, John P M ^a  

^a HANSON INSTITUTE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c Ellex Medical Lasers R and D   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BETA CRYSTALLIN; CILIARY NEUROTROPHIC FACTOR; CYCLINE; FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN 27; HEME OXYGENASE 1; MATRIX METALLOPROTEINASE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; ASTROCYTE; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; GLIA CELL; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERMEDIATE FILAMENT; LASER; LASER COAGULATION; LOW LEVEL LASER THERAPY; MICROGLIA; MUELLER CELL; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA HEMORRHAGE; RETINA INJURY; RETINA MACULA EDEMA; VERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLAST GROWTH FACTOR 2; HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERMEDIATE FILAMENT PROTEINS; LASER COAGULATION; NANOTECHNOLOGY; NEUROGLIA; RATS; RETINA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84875686200     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11204     Document Type: Article

References (66)

1. Goyal S, Lavalley M, Subramanian ML. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2011;249:15-27.
2. Lim JW, Lee HK, Shin MC. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial. Ophthalmologica. 2012;227:100-106.
3. Soheilian M, Garfami KH, Ramezani A, Yaseri M, Peyman GA. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema. Retina. 2012;32:314-321.
4. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103:1796-1806.
5. Akduman L, Olk RJ. Laser photocoagulation of diabetic macular edema. Ophthalmic Surg Lasers. 1997;28:387-408.
6. Dorin G. Evolution of retinal laser therapy: minimum intensity photocoagulation (MIP). Can the laser heal the retina without harming it? Semin Ophthalmol. 2004;19:62-68.
7. Jain A, Blumenkranz MS, Paulus Y, et al. Effect of pulse duration on size and character of the lesion in retinal photocoagulation. Arch Ophthalmol. 2008;126:78-85.
8. Marshall J. Thermal and mechanical mechanisms in laser damage to the retina. Invest Ophthalmol. 1970;9:97-115.
9. Marshall J, Hamilton AM, Bird AC. Histopathology of ruby and argon laser lesions in monkey and human retina. A comparative study. Br J Ophthalmol. 1975;59:610-630.
10. Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev. 2012;8: 274-284.
11. Paulus YM, Jain A, Gariano RF, et al. Healing of retinal photocoagulation lesions. Invest Ophthalmol Vis Sci. 2008;49: 5540-5545.
12. Akduman L, Olk RJ. Diode laser (810 nm) versus argon green (514 nm) modified grid photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1997;104:1433-1441.
13. Lavinsky D, Cardillo JA, Melo LA Jr., Dare A, Farah ME, Belfort R Jr. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema. Invest Ophthalmol Vis Sci. 2011;52:4314-4323.
14. Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol. 2005; 89:74-80.
15. Roider J, Liew SH, Klatt C, et al. Selective retina therapy (SRT) for clinically significant diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2010;248:1263-1272.
16. Wood JP, Plunkett M, Previn V, Chidlow G, Casson RJ. Nanosecond pulse lasers for retinal applications. Lasers Surg Med. 2011;43:499-510.
17. Casson RJ, Raymond G, Newland HS, Gilhotra JS, Gray TL. Pilot randomized trial of a nanopulse retinal laser versus conventional photocoagulation for the treatment of diabetic macular oedema. Clin Experiment Ophthalmol. 2012;40:604-610.
18. Wood JPM, Shibeeb O, Plunkett M, Casson RJ, Chidlow G. Retinal damage profiles and neuronal effects of laser treatment: comparison of a conventional photocoagulator and a novel, 3-nanosecond pulse laser. Invest Ophthalmol Vis Sci. 2013;54:2305-2318.
19. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607-655.
20. Bramall AN, Wright AF, Jacobson SG, McInnes RR. The genomic, biochemical, and cellular responses of the retina in inherited photoreceptor degenerations and prospects for the treatment of these disorders. Annu Rev Neurosci. 2010;33: 441-472.
21. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
22. Humphrey MF, Chu Y, Mann K, Rakoczy P. Retinal GFAP and bFGF expression after multiple argon laser photocoagulation injuries assessed by both immunoreactivity and mRNA levels. Exp Eye Res. 1997;64:361-369.
23. Humphrey MF, Constable IJ, Chu Y, Wiffen S. A quantitative study of the lateral spread of Muller cell responses to retinal lesions in the rabbit. J Comp Neurol. 1993;334:545-558.
24. Tackenberg MA, Tucker BA, Swift JS, et al. Muller cell activation, proliferation and migration following laser injury. Mol Vis. 2009;15:1886-1896.
25. Kohno H, Sakai T, Kitahara K. Induction of nestin, Ki-67, and cyclin D1 expression in Muller cells after laser injury in adult rat retina. Graefes Arch Clin Exp Ophthalmol. 2006;244:90-95.
26. Musashi K, Kiryu J, Miyamoto K, et al. Thrombin inhibitor reduces leukocyte-endothelial cell interactions and vascular leakage after scatter laser photocoagulation. Invest Ophthalmol Vis Sci. 2005;46:2561-2566.
27. Nonaka A, Kiryu J, Tsujikawa A, et al. Inflammatory response after scatter laser photocoagulation in nonphotocoagulated retina. Invest Ophthalmol Vis Sci. 2002;43:1204-1209.
28. Richardson PR, Boulton ME, Duvall-Young J, McLeod D. Immunocytochemical study of retinal diode laser photocoagulation in the rat. Br J Ophthalmol. 1996;80:1092-1098.
29. Yamamoto C, Ogata N, Yi X, et al. Immunolocalization of basic fibroblast growth factor during wound repair in rat retina after laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 1996;234:695-702.
30. Pelosini L, Hamilton R, Mohamed M, Hamilton AP, Marshall J. Retina rejuvenation therapy for diabetic macular edema: a pilot study. Retina. 2013;33:548-558.
31. Chidlow G, Wood JP, Manavis J, Osborne NN, Casson RJ. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest Ophthalmol Vis Sci. 2008;49:762-771.
32. Chidlow G, Holman MC, Wood JP, Casson RJ. Spatiotemporal characterization of optic nerve degeneration after chronic hypoperfusion in the rat. Invest Ophthalmol Vis Sci. 2010;51: 1483-1497.
33. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
34. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern guidelines: Diabetic Retinopathy. San Francisco: American Academy of Ophthalmology; 2008.
35. Bandello F, Cunha-Vaz J, Chong NV, et al. New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel. Eye (Lond). 2012;26:485-493.
36. Graham CE, Binz N, Shen WY, Constable IJ, Rakoczy EP. Laser photocoagulation: ocular research and therapy in diabetic retinopathy. Adv Exp Med Biol. 2006;572:195-200.
37. Wallenten KG, Malmsjo M, Andreasson S, Wackenfors A, Johansson K, Ghosh F. Retinal function and PKC alpha expression after focal laser photocoagulation. Graefes Arch Clin Exp Ophthalmol. 2007;245:1815-1824.
38. Wilson AS, Hobbs BG, Shen WY, et al. Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci. 2003;44:1426-1434.
39. Olk RJ. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1986;93:938-950.
40. Belokopytov M, Belkin M, Dubinsky G, Epstein Y, Rosner M. Development and recovery of laser-induced retinal lesion in rats. Retina. 2010;30:662-670.
41. Solberg Y, Rosner M, Turetz J, Belkin M. MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Invest Ophthalmol Vis Sci. 1997;38:1380-1389.
42. Marshall J, Mellerio HJ. Histology of retinal lesions produced with Q-switched lasers. Exp Eye Res. 1968;7:225-230.
43. Bringmann A, Pannicke T, Grosche J, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25:397-424.
44. von Bohlen und Halbach O. Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus. Cell Tissue Res. 2011;345:1-19.
45. Wan J, Zheng H, Chen ZL, Xiao HL, Shen ZJ, Zhou GM. Preferential regeneration of photoreceptor from Muller glia after retinal degeneration in adult rat. Vision Res. 2008;48: 223-234.
46. Xiao M, McLeod D, Cranley J, Williams G, Boulton M. Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol. 1999;83:728-736.
47. Xiao M, Sastry SM, Li ZY, et al. Effects of retinal laser photocoagulation on photoreceptor basic fibroblast growth factor and survival. Invest Ophthalmol Vis Sci. 1998;39:618-630.
48. Honjo M, Tanihara H, Kido N, Inatani M, Okazaki K, Honda Y. Expression of ciliary neurotrophic factor activated by retinal Muller cells in eyes with NMDA-and kainic acid-induced neuronal death. Invest Ophthalmol Vis Sci. 2000;41:552-560.
49. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27:622-647.
50. Head MW, Goldman JE. Small heat shock proteins, the cytoskeleton, and inclusion body formation. Neuropathol Appl Neurobiol. 2000;26:304-312.
51. Humphrey MF, Moore SR. Microglial responses to focal lesions of the rabbit retina: correlation with neural and macroglial reactions. Glia. 1996;16:325-341.
52. Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci. 2008;49:4169-4176.
53. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010;58:253-263.
54. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest. 2012;122:1164-1171.
55. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5:629-640.
56. Kadhim HJ, Duchateau J, Sebire G. Cytokines and brain injury: invited review. J Intensive Care Med. 2008;23:236-249.
57. Basu A, Krady JK, Levison SW. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004;78:151-156.
58. Crane IJ, Liversidge J. Mechanisms of leukocyte migration across the blood-retina barrier. Semin Immunopathol. 2008; 30:165-177.
59. Shaftel SS, Carlson TJ, Olschowka JA, Kyrkanides S, Matousek SB, O'Banion MK. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophilindependent blood brain barrier permeability without overt neurodegeneration. J Neurosci. 2007;27:9301-9309.
60. Vecil GG, Larsen PH, Corley SM, et al. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J Neurosci Res. 2000;61:212-224.
61. Gosselin D, Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav Immun. 2007;21:281-289.
62. Del Rio P, Irmler M, Arango-Gonzalez B, et al. GDNF-induced osteopontin from Muller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia. 2011;59:821-832.
63. Ellison JA, Barone FC, Feuerstein GZ. Matrix remodeling after stroke. De novo expression of matrix proteins and integrin receptors. Ann N Y Acad Sci. 1999;890:204-222.
64. Brinkmann R, Huttmann G, Rogener J, Roider J, Birngruber R, Lin CP. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg Med. 2000;27:451-464.
65. Sramek C, Mackanos M, Spitler R, et al. Non-damaging retinal phototherapy: dynamic range of heat shock protein expression. Invest Ophthalmol Vis Sci. 2011;52:1780-1787.
66. Luttrull JK, Sramek C, Palanker D, Spink CJ, Musch DC. Longterm safety, high-resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina. 2012;32:375-386.